Effects of a Low-FODMAP Diet on Irritable Bowel Syndrome in Both Children and Adults-A Narrative Review

• Published in: Nutrients Vol. 15; no. 10; p. 2295
• Main Authors: Morariu, Ionela-Daniela, Avasilcai, Liliana, Vieriu, Madalina, Lupu, Vasile Valeriu, Morariu, Branco-Adrian, Lupu, Ancuța, Morariu, Paula-Cristina, Pop, Oana-Lelia, Starcea, Iuliana Magalena, Trandafir, Laura
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 13.05.2023; MDPI
• Subjects: Abdomen; Abdominal Pain - drug therapy; Abdominal Pain - etiology; Adult; Adults; Analysis; Anti-inflammatory agents; Antibiotics; Biomarkers; Child; Children; Clinical trials; Constipation; Diarrhea; Diet; Diet, Carbohydrate-Restricted; Disaccharides; Disease; Fermentation; Flatulence; FODMAP Diet; Food allergies; Gastrointestinal diseases; Gastrointestinal Diseases - drug therapy; Gastrointestinal symptoms; Humans; Inflammation; Inflammatory bowel disease; Intestine; Irritable Bowel Syndrome; Literature reviews; low-FODMAP diet; Microbiota; Monosaccharides; Motility; Narratives; Nervous system; Neutrophils; Nutrient deficiency; Oligosaccharides; Pain; Pathology; Pathophysiology; Polyols; Quality of Life; Review; Serology; Sugars; Systematic Reviews as Topic; Womens health; low-FODMAP diet; monosaccharides; disaccharides; irritable bowel syndrome; oligosaccharides
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu15102295

Irritable bowel syndrome is a typical gastrointestinal disease that causes bloating, flatulence, abdominal pain, diarrhoea, constipation, or alteration of the last two in adults and children. A diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) is one of the potential treatment strategies to reduce abdominal symptoms and increase the quality of life. The present narrative review aims to present a general overview of current studies that have evaluated the efficacy of a low-FODMAP diet against other diets in gastrointestinal symptoms, nutrient intake in adults and children, and lifestyle quality. The research was performed using seven searchable databases, which included the Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Database of Systematic Reviews (CDSR), Excerpta Medica Database (EMBASE), Medline, PubMed, Scopus, and Web of Science, up to March 2023. In conclusion, there is significant evidence that the follow-up of a low-FODMAP diet might be a feasible first-line therapeutic strategy to reduce stomach discomfort, pain, bloating, and quality of life for patients with irritable bowel syndrome.